Dr. Prerna Chanana, a physician and drug safety leader with more than 16 years of experience across clinical medicine, pharmaceutical development, and pharmacovigilance. Throughout her career, she had the privilege of supporting drug development programs from early-phase research through post-marketing surveillance, with a particular focus on oncology and innovative therapies.

Her work has centred on transforming complex safety data into actionable benefit-risk insights that inform regulatory strategy, clinical development, and ultimately patient care. Leading global safety activities across clinical programs, including signal detection and management, aggregate reporting, safety governance, and medical review, while collaborating closely with cross-functional teams and executive leadership.